Aiforia Technologies Oyj announced appointment of Richard Haworth to its Scientific Advisory Board. He is a Founder of RosettaPath Ltd., providing digital, research, and toxicologic pathology consultancy across various sectors including biotech, pharmaceuticals, contract research organizations (CROs), software vendors, and academia. Prior to RosettaPath, Haworth led the Global Pathology team within Clinical Pharmacology and Safety Sciences at AstraZeneca and before that, he served as Head of the UK Pathology department at GSK.

He earned his veterinary medicine degree from the University of Cambridge and completed a PhD at Oxford University, focusing on experimental pathology and immunology. Haworth holds board certifications in veterinary pathology (FRCPath, Diplomate of the European College of Veterinary Pathologists) and toxicology (Diplomate of the American Board of Toxicology). In March 2024, Haworth achieved accreditation as a Full Fellow of the International Academy of Toxicologic Pathology.